ALEC
ALEC
NASDAQ · Biotechnology

Alector Inc

$2.16
-0.14 (-6.09%)
As of May 16, 2:05 AM ET ·
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Buy 8 57%
Hold 4 29%
Sell 2 14%
Price Target
Analyst Price Target +886.1% upside
Low Target $14.71
Average Target $21.30
High Target $34.17
Current Price $2.16
Current
$2.16
Target
$21.30
$14.71 $21.30 avg $34.17
Scenario Analysis
Bear Case
$14.71
581.0%
Low target
Base Case
$21.30
+886.1%
Avg target
Bull Case
$34.17
+1,481.9%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$3.40
-36.5% from high
52-Week Low
$1.01
+113.9% from low
Target vs 52W High
$21.30
+526.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%